Portage Biotech Inc. - Common Stock (PRTG)

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Which stocks have an unusual volume on Friday?

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Portage Biotech unveils new preclinical data on PORT-7, showing strong antitumor effects in mesothelioma and advancing plans for clinical trials.

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

The company shared new data on PORT-7, a selective A2B receptor inhibitor, showing significant tumor growth inhibition in a mesothelioma model.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Portage Biotech stock is trading higher after the company announced it signed a letter of intent with Immunova for the potential sale of its subsidiary.